McKesson · 3 hours ago
Senior Financial Analyst
McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. They are seeking a Senior Financial Analyst to support large SNA customers and the Retail National Account team by performing financial analysis, forecasting, and reporting.
BiopharmaBiotechnologyHealth CareInformation TechnologyPharmaceutical
Responsibilities
Attend business partner team meetings / relationship management
Perform variance analysis against forecasts and budgets
Prepare standard management and executive-level reporting
Perform process improvements and special projects
Qualification
Required
Degree or equivalent and typically requires 4+ years of relevant experience
Ability to interpret financial data and communicate results clearly (written and verbal); translate numbers into stories
Experience with SAP or another large ERP
Intermediate to Advanced MS Excel skills
Excellent verbal and written communication with ability to manage multiple projects simultaneously
Experience working in a team environment
Excellent organizational skills, teamwork, and interpersonal skills
Process improvement experience
Adaptable to changing environment/technology
Bachelor's degree in finance, accounting, or related field or equivalent experience
Preferred
CPA or MBA preferred
Public accounting experience is a plus
Experience in healthcare industry is a plus
Experience in corporate finance is a plus
Benefits
Competitive compensation package
Annual bonus
Long-term incentive opportunities
Company
McKesson
McKesson distributes medical supplies, information technology, and care management products and services.
H1B Sponsorship
McKesson has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (149)
2024 (129)
2023 (82)
2022 (142)
2021 (144)
2020 (154)
Funding
Current Stage
Public CompanyTotal Funding
unknown1994-11-18IPO
Recent News
2026-01-23
2026-01-12
Company data provided by crunchbase